Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
Cell Discov
.
2020 Oct 13:6:71.
doi: 10.1038/s41421-020-00217-2.
eCollection 2020.
Authors
Pei-Gang Wang
1
,
Dong-Jiang Tang
2
3
,
Zhan Hua
4
,
Zai Wang
5
,
Jing An
1
Affiliations
1
Department of Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069 China.
2
Zhuhai SanMed Biotech Ltd, Zhuhai, 519000 China.
3
Joint Research Center of Liquid Biopsy in Guangdong, Hong Kong and Macau, Zhuhai, 519000 China.
4
Department of General Surgery, China-Japan Friendship Hospital, 100029 Beijing, China.
5
Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, 100029 Beijing, China.
PMID:
33083006
PMCID:
PMC7550610
DOI:
10.1038/s41421-020-00217-2
No abstract available
Keywords:
Endocytosis; Membrane fusion.